网站综合信息 www.palatin.com
    • 标题:
    • Palatin Technologies - The Leader in M 
    • 关键字:
    •  
    • 描述:
    • Palatin Technologies Presents Bremelanotide Alcohol Interaction Study at ... Palatin Technologies, I 
    • 域名信息
    • 域名年龄:27年10个月24天  注册日期:1996年10月13日  到期时间:2017年10月12日
      邮箱:LJANECZKO  电话:+1.6094952291
      注册商:ENOM, INC. 
    • 服务器空间
    • IP:35.196.57.42
      地址:美国 Merit网络公司
    • 备案信息
    • 备案号: 
    网站收录SEO数据
    • 搜索引擎
    • 收录量
    • 反向链接
    • 其他
    • 百度
    • 6  
    • 47  
    • 快照:2014-06-27  
    • Google
    • 347  
    • 12  
    • pr:4  
    • 雅虎
    • 0  
    •  
    •  
    • 搜搜
    • 0  
    •  
    •  
    • 搜狗
    • 0  
    •  
    • 评级:3/10  
    • 360搜索
    • 0  
    •  
    •  
    域名流量Alexa排名
    •  
    • 一周平均
    • 一个月平均
    • 三个月平均
    • Alexa全球排名
    • -  
    • 平均日IP
    • 日总PV
    • 人均PV(PV/IP比例)
    • 反向链接
    • dmoz目录收录
    • -  
    • 流量走势图
    域名注册Whois信息

    palatin.com

    域名年龄: 27年10个月24天
    注册时间: 1996-10-13
    到期时间: 2017-10-12
    注 册 商: ENOM, INC.
    注册邮箱: LJANECZKO
    联系电话: +1.6094952291

    获取时间: 2016年12月28日 11:26:40
    Domain Name: PALATIN.COM
    Registrar: ENOM, INC.
    Sponsoring Registrar IANA ID: 48
    Whois Server: whois.enom.com
    Referral URL: http://www.enom.com
    Name Server: DNS1.NAME-SERVICES.COM
    Name Server: DNS2.NAME-SERVICES.COM
    Name Server: DNS3.NAME-SERVICES.COM
    Name Server: DNS4.NAME-SERVICES.COM
    Name Server: DNS5.NAME-SERVICES.COM
    Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
    Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
    Updated Date: 2016-09-13
    Creation Date: 1996-10-13
    Expiration Date: 2017-10-12

    >>> Last update of whois database: Wed, 2016-Dec-28 03:33:18 GMT <<<

    For more information on Whois status codes, please visit https://icann.org/epp

    Domain Name: PALATIN.COM
    Registry Domain ID: 479459_DOMAIN_COM-VRSN
    Registrar WHOIS Server: whois.enom.com
    Registrar URL: www.enom.com
    Updated Date: 2016-12-23T07:42:10.00Z
    Creation Date: 1996-10-13T00:00:00.00Z
    Registrar Registration Expiration Date: 2017-10-12T04:00:00.00Z
    Registrar: ENOM, INC
    Registrar IANA ID: 48
    Domain Status: clientTransferProhibited https://www.icann.org/epp#clientTransferProhibited
    Registry Registrant ID:
    Registrant Name: NULL NULL
    Registrant Organization: PALATIN TECHNOLOGIES, INC
    Registrant Street: 4-C CEDAR BROOK DRIVE / CEDARBROOK CORPORATE CENTER
    Registrant City: CRANBURY
    Registrant State/Province: NJ
    Registrant Postal Code: 08512
    Registrant Country: US
    Registrant Phone: NULL
    Registrant Phone Ext:
    Registrant Fax:
    Registrant Fax Ext:
    Registrant Email: NA
    Registry Admin ID:
    Admin Name: LES JANECZKO
    Admin Organization: PALATIN TECHNOLOGIES, INC.
    Admin Street: 4B CEDAR BROOK DRIVE
    Admin City: CRANBURY
    Admin State/Province: NJ
    Admin Postal Code: 08512
    Admin Country: US
    Admin Phone: +1.6094952291
    Admin Phone Ext:
    Admin Fax: +1.6094952202
    Admin Fax Ext:
    Admin Email: LJANECZKO
    Registry Tech ID:
    Tech Name: LES JANECZKO
    Tech Organization: PALATIN TECHNOLOGIES, INC.
    Tech Street: 4B CEDAR BROOK DRIVE
    Tech City: CRANBURY
    Tech State/Province: NJ
    Tech Postal Code: 08512
    Tech Country: US
    Tech Phone: +1.6094952291
    Tech Phone Ext:
    Tech Fax: +1.6094952202
    Tech Fax Ext:
    Tech Email: LJANECZKO
    Name Server: DNS1.NAME-SERVICES.COM
    Name Server: DNS2.NAME-SERVICES.COM
    Name Server: DNS3.NAME-SERVICES.COM
    Name Server: DNS4.NAME-SERVICES.COM
    Name Server: DNS5.NAME-SERVICES.COM
    DNSSEC: unSigned
    Registrar Abuse Contact Email: abuse
    Registrar Abuse Contact Phone: +1.4252982646
    URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
    >>> Last update of WHOIS database: 2016-12-23T07:42:10.00Z <<<

    For more information on Whois status codes, please visit https://icann.org/epp

    We reserve the right to modify these terms at any time. By submitting
    this query, you agree to abide by these terms.
    Version 6.3 4/3/2002

    Get Noticed on the Internet! Increase visibility for this domain name by listing it at www.whoisbusinesslistings.com
    同IP网站(同服务器)
  • 35.196.57.42 (美国 Merit网络公司)
  • Palatin Technologies - T
  • 其他后缀域名
    • 顶级域名
    • 相关信息
    网站首页快照(纯文字版)
    抓取时间:2019年07月14日 13:02:31
    网址:http://www.palatin.com/
    标题:Palatin Technologies - The Leader in Melanocortin-based Ther
    关键字:
    描述:Palatin Technologies Presents Bremelanotide Alcohol Interaction Study at ... Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2016 Results.
    主体:
    Press ReleasesAbout UsExecutive ManagementBoard of DirectorsPalatin Scientific AdvisorsCareers at PalatinCorporate GovernanceReporting HotlineResearch FocusClinical PipelineOur Focus: Peptide DrugsFemale Sexual DysfunctionHSDDVyleesi LicenseVyleesiPhase 3 Reconnect StudiesPhase 2B Clinical Trial ResultsHeart FailureInflammatory DiseaseObesity and DiabetesLicensing & CollaborationInvestorsOverviewPress Releases
    Event Calendar
    Archived Events
    Webcasts
    SEC Filings
    Analyst Coverage
    Investor Resources
    Resources
    Corporate Presentation
    Vyleesi™ (bremelanotide) for Hypoactive Sexual Desire Disorder (HSDD)
    Poster Presentations
    Female Sexual Dysfunction Related Videos: Expert Discussion
    Scientific Publications
    Patent Portfolio
    Helpful Links
    Contact Us
    Contacting Palatin
    
    Drug therapies activating the power of your body
    Palatin Technologies develops peptide therapeutics for diseases with significant unmet medical need and commercial potential.
    Learn More
    Female Sexual Dysfunction
    Vyleesi is an on-demand treatment for the most common type of female sexual dysfunction.
    Learn More
    Improving quality of life for patients with heart failure
    Natriuretic peptide mimetics for heart failure, providing increased therapeutic options.
    Learn More
    Obesity and Diabetes
    Peptide therapeutics to help regulate eating behavior and energy balance, leading to decreased food intake and weight loss.
    Learn More
    Inflammatory Diseases
    Using the melanocortin receptor-1 system to help control inflammatory and autoimmune diseases like inflammatory bowel disease, nephritis and uveitis.
    Learn More
    
    
    Palatin Technologies, Inc.Female Sexual DysfunctionHeart FailureObesity and DiabetesInflammatory Diseases
    Pipeline
    Pipeline
    Status of our clinical and preclinical programs, including our inflammatory and heart disease programs.
    Learn More
    Investors
    Investors
    Learn about Palatin, including press releases, presentations, filings with the Securities and Exchange Commission and more.
    Learn More
    News
    News
    The latest news about Palatin, with the full text of press releases issued by Palatin.
    Learn More
    Upcoming Events
    Upcoming Events
    Scheduled presentations by Palatin senior management, quarterly calls, scientific presentations and other upcoming events.
    Learn More
    Corporate Presentation
    Corporate Presentation
    Palatin’s corporate presentation, with an emphasis on Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD), and other pipeline development programs.
    Learn More
    © 2019 Palatin Technologies, Inc. All rights reserved.
    Privacy Policy
    Terms of Use
    Contact Us
    Sitemap

    © 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询

    2024-08-26 20:46, Process in 0.0051 second.